{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-009610","form_type":"8-K","ticker":"INFU","cik":"0001337013","company_name":"InfuSystem Holdings, Inc","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.382276+00:00","generated_at":"2026-05-25T13:25:16.738041+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"InfuSystem reports record 2024 revenue of $134.9M, +7% YoY; Adj EBITDA +13% to $25.3M; guides 2025 revenue growth 8-10%","bullets":["Q4 net revenues $33.8M (+7% YoY); net income $0.9M ($0.04 EPS) vs $0.1M prior year.","Full year adj EBITDA $25.3M (+13%); operating cash flow $20.5M (+82%).","Patient Services rev $80.4M (+5%), Device Solutions $54.5M (+11%) for full year.","2025 guidance: revenue growth 8-10%, adj EBITDA margin above 18.8%.","Repurchased $1.2M in 2024 and ~$2.4M in Q1 2025; net debt down $5.5M to $23.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-009610","json":"https://secwatch.observer/filing/0001628280-25-009610.json","markdown":"https://secwatch.observer/filing/0001628280-25-009610.md","text":"https://secwatch.observer/filing/0001628280-25-009610.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025009610/0001628280-25-009610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1337013/000162828025009610/infu-20250304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T13:25:16.738041+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}